CTRI Number |
CTRI/2020/04/024510 [Registered on: 08/04/2020] Trial Registered Prospectively |
Last Modified On: |
25/11/2024 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
The effect of good pain relief on arm movement following surgeries for fractures around the elbow |
Scientific Title of Study
|
Effect of patient controlled continuous infraclavicular block on early functional rehabilitation following surgeries for fractures around the elbow |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Arun Jagath A S |
Designation |
Junior Resident, Department of Anaesthesia |
Affiliation |
PGIMER, Chandigarh |
Address |
House number 2114 , sector 15 c , Chandigarh
Chandigarh CHANDIGARH 160015 India |
Phone |
9717828974 |
Fax |
|
Email |
jagath9717@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Arun Jagath A S |
Designation |
Junior Resident, Department of Anaesthesia |
Affiliation |
PGIMER, Chandigarh |
Address |
House number 2114 , sector 15 c , Chandigarh
Chandigarh CHANDIGARH 160015 India |
Phone |
9717828974 |
Fax |
|
Email |
jagath9717@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Nidhi Bhatia |
Designation |
Additional Professor |
Affiliation |
PGIMER, Chandigarh |
Address |
Dept of Anaesthesia and Intensive Care
Nehru Hospital
PGIMER
Sector 12
Chandigarh CHANDIGARH 160012 India |
Phone |
9914207483 |
Fax |
|
Email |
nidhi.bhatia75@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
PGIMER |
Address |
Sector 12, Chandigarh |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Arun Jagath AS |
PGIMER |
Department of Anaesthesia and Intensive Care, PGIMER, Sector 12, Chandigarh Chandigarh CHANDIGARH |
9717828974
jagath9717@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
infraclavicular brachial plexus block Group |
patients will receive continuous infraclavicular brachial plexus block using 0.2% Ropivacaine at a basal rate of 5 ml / hr, with a patient controlled bolus of 3ml and a lockout interval of 30 minutes . |
Comparator Agent |
Intravenous group |
patients will receive intravenous PCA in the postoperative period, using patient controlled bolus of 1mg Morphine intravenously with a lockout interval of 15 minutes. |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
patients scheduled to undergo open reduction, internal fixation surgery for fractures around the elbow, under general anaesthesia will be enrolled in the study. |
|
ExclusionCriteria |
Details |
â– Local infection at the block site
â– Brachial plexus injury
â– Coagulopathy
â– Sepsis
â– Obesity (BMI>30)
â– Allergy to local anesthetics / opioids
â– Uncontrolled hypertension or ischemic heart disease
â– Renal or hepatic dysfunction
â– Bronchopulmonary disorders
â– Pre-existing neurological deficit
â– Prior surgery in the infraclavicular area
â– Psychiatric illness
â– Inability to cooperate or understand the study protocol.
â– Patients who fail to understand the scoring systems used in the study
â– Refusal to give consent for the study
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Mayo Elbow Performance Score |
3 weeks following discharge |
|
Secondary Outcome
|
Outcome |
TimePoints |
1.Mayo Elbow Performance Score at 3 months following discharge from the hospital
2. Numeric rating scale (NRS) score 4 hourly for 72 hours
3. NRS score at the time of physiotherapy
4. Perioperative consumption of bolus doses of opioids and local anaesthetics in the initial 72 hours after surgery
5. Total dosage of rescue analgesic consumed in 72 hours.
6. Time to first dose of rescue analgesia
7. Any complications (including nausea, vomiting, sedation) in the postoperative period.
|
3 months - mayo elbow performance score
NRS- 4hourly for 72 hours
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
15/04/2020 |
Date of Study Completion (India) |
Date Missing |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This
prospective, randomised clinical trial will be conducted in the department of
Anaesthesia and Intensive Care, PGIMER, Chandigarh with the aim of
investigating the effect of analgesia via patient controlled continuous
infraclavicular brachial plexus block technique, on early functional
rehabilitation after surgery for fractures around elbow. Patients will be allocated to one of the two groups of 20 patients each: Group I
patients (n=20) will receive intravenous PCA in the postoperative period, using
patient controlled bolus of 1mg Morphine intravenously with a lockout interval
of 15 minutes.Group II
patients (n=20) will receive continuous
infraclavicular brachial plexus block using 0.2% Ropivacaine at a basal rate of
5 ml / hr, with a patient controlled bolus of 3ml and a lockout interval of 30
minutes. All patients will be assessed after
3 weeks and 3 months following discharge. MEPS score will be assessed during
these sessions by an assessor who is blinded to the group allocations. |